Prediction and biochemical characterization of intrinsic disorder in the structure of proteolysis-inducing factor/dermcidin

Genetics and Molecular Research

Volumn 6, Issue 4, 2007, Pages 1000-1011

  Majczak, G ^a   Lilla, S ^a   Garay Malpartida, M ^a   Markovic, J ^a   Medrano, F J ^b   De Nucci, G ^a   Belizario J E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b LABORATÓRIO NACIONAL DE LUZ SÍNCROTRON   (Brazil)

Author keywords

Antimicrobial peptides; Circular dichroism; Intrinsically unstructured proteins

Indexed keywords

AMINO ACID; CYSTEINE DERIVATIVE; DERMCIDIN; DISULFIDE; DODECYL SULFATE SODIUM; MONOMER; POLYPEPTIDE; RECOMBINANT PROTEIN; TRIFLUOROETHANOL; TRYPSIN; WATER;

ALPHA HELIX; AMINO ACID SEQUENCE; AQUEOUS SOLUTION; BETA SHEET; BIOLOGICAL ACTIVITY; CELL SURVIVAL; CHEMICAL ANALYSIS; CIRCULAR DICHROISM; COMPUTER MODEL; CONFERENCE PAPER; CRYSTALLIZATION; ESCHERICHIA COLI; MASS SPECTROMETRY; NERVE CELL; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREDICTION; PREDICTOR VARIABLE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; PROTEIN SECONDARY STRUCTURE;

AMINO ACID SEQUENCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCULAR DICHROISM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT PROTEINS; SOFTWARE;

ESCHERICHIA COLI;

EID: 37349057093     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (30)

1. Cunningham TJ, Hodge L, Speicher D, Reim D, et al. (1998). Identification of a survival-promoting peptide in medium conditioned by oxidatively stressed cell lines of nervous system origin. J. Neurosci. 18: 7047-7060.
2. Cunningham TJ, Jing H, Wang Y and Hodge L (2000). Calreticulin binding and other biological activities of survival peptide Y-P30 including effects of systemic treatment of rats. Exp. Neurol. 163: 457-468.
3. Cunningham TJ, Jing H, Akerblom I, Morgan R, et al. (2002). Identification of the human cDNA for new survival/evasion peptide (DSEP): studies in vitro and in vivo of overexpression by neural cells. Exp. Neurol. 177: 32-39.
4. Deans DA, Wigmore SJ, Gilmour H, Tisdale MJ, et al. (2006). Expression of the proteolysis-inducing factor core peptide mRNA is upregulated in both tumor and adjacent normal tissue in gastro-oesophageal malignancy. Br. J. Cancer 94: 731-736.
5. Garay-Malpartida HM (2004). Clonagem, expressão e caracterização funcional da proteína hPIF (human proteolysis-inducing factor). Doctoral thesis, Universidade de São Paulo, São Paulo.
6. Iakoucheva LM and Dunker AK (2003). Order, disorder, and flexibility: prediction from protein sequence. Structure 11: 1316-1317.
7. Kufe D (2004). Modulation of the interaction of MUC1 with MUC1 ligands. United States Patent Office. Patent Application 60/519,822.
8. Lai YP, Peng YF, Zuo Y, Li J, et al. (2005). Functional and structural characterization of recombinant dermcidin-1L, a human antimicrobial peptide. Biochem. Biophys. Res. Commun. 328: 243-250.
9. Li XP, Romero PM, Rani M, Dunker AK, et al. (1999). Predicting protein disorder for N-, C-, and internal regions. Genome Informatics 10: 30-40.
10. Linding R, Jensen LJ, Diella F, Bork P, et al. (2003a). Protein disorder prediction: implications for structural proteomics. Structure 11: 1453-1459.
11. Linding R, Russell RB, Neduva V and Gibson TJ (2003b). GlobPlot: exploring protein sequences for globularity and disorder. Nucleic Acids Res. 31: 3701-3708.
12. Lowrie AG, Wigmore SJ, Wright DJ, Waddell ID, et al. (2006). Dermcidin expression in hepatic cells improves survival without N-glycosylation, but requires asparagine residues. Br. J. Cancer 94: 1663-1671.
13. Majczak G (2005). Caracterização estrutural da proteína recombinante rhPIF/DCD (proteolysis-inducing factor/dermcidin). Doctoral thesis, Universidade de São Paulo, São Paulo.
14. Markovic J (2003). Expressão gênica do fator indutor de proteólise celular (PIF) e de sua forma variante (PIF-SV) em células normais e malignas. Master's thesis, Universidade de São Paulo, São Paulo.
15. Minami Y, Uede K, Sagawa K, Kimura A, et al. (2004). Immunohistochemical staining of cutaneous tumours with G-81, a monoclonal antibody to dermcidin. Br. J. Dermatol. 151: 165-169.
16. Oldfield CJ, Ulrich EL, Cheng Y, Dunker AK, et al. (2005). Addressing the intrinsic disorder bottleneck in structural proteomics. Proteins 59: 444-453.
17. Porter D, Weremowicz S, Chin K, Seth P, et al. (2003). A neural survival factor is a candidate oncogene in breast cancer. Proc. Nat. Acad. Sci. USA 100: 10931-10936.
18. Rieg S, Garbe C, Sauer B, Kalbacher H, et al. (2004). Dermcidin is constitutively produced by eccrine sweat glands and is not induced in epidermal cells under inflammatory skin conditions. Br. J. Dermatol. 151: 534-539.
19. Rogers S, Wells R and Rechsteiner M (1986). Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 234: 364-368.
20. Romero P, Obradovic Z and Dunker AK (2004). Natively disordered proteins: functions and predictions. Appl. Bioinformatics 3: 105-113.
21. Scapin SM, Carneiro FR, Alves AC, Medrano FJ, et al. (2006). The crystal structure of the small GTPase Rab11b reveals critical differences relative to the Rab11a isoform. J. Struct. Biol. 154: 260-268.
22. Schittek B, Hipfel R, Sauer B, Bauer J, et al. (2001). Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat. Immunol. 2: 1133-1137.
23. Steffen H, Rieg S, Wiedemann I, Kalbacher H, et al. (2006). Naturally processed dermcidin-derived peptides do not permeabilize bacterial membranes and kill microorganisms irrespective of their charge. Antimicrob. Agents Chemother. 50: 2608-2620.
24. Tisdale MJ (2004). Tumor-host interactions. J. Cell. Biochem. 93: 871-877.
25. Todorov P, Cariuk P, McDevitt T, Coles B, et al. (1996). Characterization of a cancer cachectic factor. Nature 379: 739-742.
26. Tompa P (2002). Intrinsically unstructured proteins. Trends Biochem. Sci. 27: 527-533.
27. Vucetic S, Obradovic Z, Vacic V, Radivojac P, et al. (2005). DisProt: a database of protein disorder. Bioinformatics 21: 137-140.
28. Wang Z, Corey E, Hass GM, Higano CS, et al. (2003). Expression of the human cachexia-associated protein (HCAP) in prostate cancer and in a prostate cancer animal model of cachexia. Int. J. Cancer 105: 123-129.
29. Wei X, Xu H and Kufe D (2007). Human mucin 1 oncoprotein represses transcription of the p53 tumor suppressor gene. Cancer Res. 67: 1853-1858.
30. Zanetti M, Gennaro R and Romeo D (1995). Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett. 374: 1-5.